Sale on Ophthalmic Equipment - Starting from 16 November!
Omron Healthcare has begun producing blood pressure monitors at its first India plant near Chennai, with a tenfold capacity target by 2028 and Europe as a potential export market.
Omron Healthcare, the medical device arm of Japan's Omron, has begun full production of blood pressure monitors at its first Indian factory. The Omron India blood pressure plant stands near Chennai in Tamil Nadu. The company says mass production started in October.
The factory covers 24,000 m² and runs five dedicated production lines. It makes monitors for Indian consumers. A subsidiary, Omron Healthcare Manufacturing India, runs the site and was set up in July 2022.
Quality standards and manufacturing know how came from Omron's Matsusaka plant in Japan and its facility in Vietnam.
Omron wants to raise the plant's capacity tenfold by 2028. Reuters reported a target of about three million units a year by then. Running three shifts could take output to about 3.5 million. Omron is aiming at India's largely underpenetrated home monitoring market.
Omron Healthcare president and CEO Ayumu Okada told Reuters that India could become one of the company's largest manufacturing bases. The site may also supply European markets in time, alongside Vietnamese output.
The first products are the HEM 7090, HEM 7181 and HEM 7183T series. They range from simple devices for new users to models with a trend indicator that flags rising readings. Those models also pair over Bluetooth with the Omron Connect health app.
Okada said local production would not lower retail prices.
The Chennai plant is part of a wider push to reduce the company's reliance on Vietnam and spread supply chain risk across more regions. Omron may later add nebuliser production for conditions such as asthma.
The plant also supports the Indian Government's Make in India programme through local sourcing and workforce development. Omron says the capacity growth, European exports and new product lines are goals, and their timing depends on demand and execution.
The Omron India blood pressure plant shows a major maker shifting output closer to its buyers and away from a single supply hub. Medigear.uk follows the Omron India blood pressure plant and wider blood pressure monitor supply news.
Source: Medical Device Network
Tell us the model and destination — our sourcing team will respond within one business day.

The Zimmer Monogram robot is now with US regulators. Zimmer Biomet has filed a 510(k) submission for…

The Abbott Encantor trial has begun. Abbott said on Thursday that it has started the VOYAGER CE clin…

Johnson & Johnson (J&J) said on Thursday that a Houston hospital will be the first to instal…
Approvals, trials, recalls and market moves — the essentials for procurement and clinical teams.